Sensient Technologies (NYSE: SXT) director adds deferred stock and updates holdings

Rhea-AI Filing Summary

Sensient Technologies Corp. director Dr. Ferruzzi reported equity holdings and a new deferred stock award. On 12/31/2025, the director acquired 58.861 shares of deferred stock, which convert to common stock on a one-for-one basis under the company’s Directors’ Deferred Compensation Plan. Following the reported transactions, the director beneficially owns 8,043.478 shares of common stock directly and 227.421 shares indirectly through a spouse’s ESOP account. Some of the directly held shares are restricted stock under the 2017 Stock Plan and shares in a dividend reinvestment plan. The deferred stock will result in common shares being issued when the director’s service with the company ends.

Insider Trade Summary

3 transactions reported

Mixed 3 txns

Insider Ferruzzi Mario

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Deferred Stock	58.861	$0.00	--
holding	Common Stock	--	--	--
holding	Common Stock	--	--	--

Holdings After Transaction: Deferred Stock — 3,245.605 shares (Direct); Common Stock — 8,043.478 shares (Direct); Common Stock — 227.421 shares (Indirect, Spouse's ESOP)

Footnotes (1)

1. Includes shares of restricted stock held under Issuer's 2017 Stock Plan, as amended and restated, and shares held in a dividend reinvestment plan. Represents shares held in Issuer's ESOP as of the end of the month immediately preceding this filing. Deferred stock converts to common stock on a one-for-one basis. Deferral of director fees under Issuer's Directors' Deferred Compensation Plan. Shares of common stock will be issued upon termination of reporting person's service as a director of the Issuer.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Ferruzzi Mario

(Last) (First) (Middle)

777 E. WISCONSIN AVENUE

(Street)

MILWAUKEE WI 53202

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
SENSIENT TECHNOLOGIES CORP [ SXT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
12/31/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock								8,043.478(1)	D
Common Stock								227.421(2)	I	Spouse's ESOP

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Deferred Stock	(3)	12/31/2025		A(4)		58.861		(5)	(5)	Common Stock	58.861	$0	3,245.605	D

Explanation of Responses:

1. Includes shares of restricted stock held under Issuer's 2017 Stock Plan, as amended and restated, and shares held in a dividend reinvestment plan.

2. Represents shares held in Issuer's ESOP as of the end of the month immediately preceding this filing.

3. Deferred stock converts to common stock on a one-for-one basis.

4. Deferral of director fees under Issuer's Directors' Deferred Compensation Plan.

5. Shares of common stock will be issued upon termination of reporting person's service as a director of the Issuer.

	/s/ John J. Manning, Attorney-in-Fact for Dr. Ferruzzi	01/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Sensient Technologies (SXT) disclose in this Form 4?

The filing shows that a director acquired 58.861 shares of deferred stock on 12/31/2025 under Sensient Technologies’ Directors’ Deferred Compensation Plan.

How many Sensient Technologies (SXT) shares does the director now beneficially own?

After the reported transaction, the director beneficially owns 8,043.478 shares of common stock directly and 227.421 shares indirectly through a spouse’s ESOP account.

What is deferred stock in this Sensient Technologies (SXT) filing?

The filing states that deferred stock converts to common stock on a one-for-one basis, with shares of common stock issued upon termination of the director’s service with Sensient Technologies.

How were the deferred stock units for the Sensient Technologies (SXT) director created?

The 58.861 deferred stock units represent a deferral of director fees under Sensient Technologies’ Directors’ Deferred Compensation Plan.

What types of Sensient Technologies (SXT) shares are included in the director’s direct holdings?

The direct holdings include restricted stock granted under the 2017 Stock Plan, as amended and restated, and shares held in a dividend reinvestment plan.

How are the indirect Sensient Technologies (SXT) shares held for the reporting person?

The filing notes that 227.421 shares are held indirectly in Sensient Technologies’ ESOP through the director’s spouse, based on the ESOP balance as of the month-end before the filing.